SE9303444D0 - New use of prostaglandins - Google Patents

New use of prostaglandins

Info

Publication number
SE9303444D0
SE9303444D0 SE9303444A SE9303444A SE9303444D0 SE 9303444 D0 SE9303444 D0 SE 9303444D0 SE 9303444 A SE9303444 A SE 9303444A SE 9303444 A SE9303444 A SE 9303444A SE 9303444 D0 SE9303444 D0 SE 9303444D0
Authority
SE
Sweden
Prior art keywords
prostaglandins
new use
prostaglandin
analogues
derivatives
Prior art date
Application number
SE9303444A
Other languages
Swedish (sv)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9303444A priority Critical patent/SE9303444D0/en
Publication of SE9303444D0 publication Critical patent/SE9303444D0/en
Priority to JP7511697A priority patent/JPH09504021A/en
Priority to PCT/SE1994/000985 priority patent/WO1995011003A1/en
Priority to AU80086/94A priority patent/AU8008694A/en
Priority to CA002174655A priority patent/CA2174655A1/en
Priority to EP94931257A priority patent/EP0724425A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

A method for producing a composition containing prostaglandins, derivatives or analogues thereof for increasing pigmentation of tissues or modified tissues, e.g. hair, is disclosed. Among these, derivatives and analogues of prostaglandin F2a and prostaglandin E2 in particular, have been found suitable for the purpose.
SE9303444A 1993-10-20 1993-10-20 New use of prostaglandins SE9303444D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9303444A SE9303444D0 (en) 1993-10-20 1993-10-20 New use of prostaglandins
JP7511697A JPH09504021A (en) 1993-10-20 1994-10-19 New use of prostaglandins
PCT/SE1994/000985 WO1995011003A1 (en) 1993-10-20 1994-10-19 New use of prostaglandins
AU80086/94A AU8008694A (en) 1993-10-20 1994-10-19 New use of prostaglandins
CA002174655A CA2174655A1 (en) 1993-10-20 1994-10-19 New use of prostaglandins
EP94931257A EP0724425A1 (en) 1993-10-20 1994-10-19 New use of prostaglandins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303444A SE9303444D0 (en) 1993-10-20 1993-10-20 New use of prostaglandins

Publications (1)

Publication Number Publication Date
SE9303444D0 true SE9303444D0 (en) 1993-10-20

Family

ID=20391475

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303444A SE9303444D0 (en) 1993-10-20 1993-10-20 New use of prostaglandins

Country Status (6)

Country Link
EP (1) EP0724425A1 (en)
JP (1) JPH09504021A (en)
AU (1) AU8008694A (en)
CA (1) CA2174655A1 (en)
SE (1) SE9303444D0 (en)
WO (1) WO1995011003A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000100A1 (en) * 1996-07-03 1998-01-08 The Board Of Regents Of The University Of Oklahoma Enhancement of skin pigmentation by prostaglandins
ATE266397T1 (en) 1997-02-04 2004-05-15 Murray A Johnstone METHOD FOR PROMOTING HAIR GROWTH AND DEVELOPMENT OF THE HAIR SYSTEM
JP4834224B2 (en) 1999-03-05 2011-12-14 デューク ユニバーシティ C16 unsaturated FP-selective prostaglandin analogs
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
FR2812192B1 (en) * 2000-07-28 2003-01-31 Oreal USE OF PROSTAGLANDIN EP-3 RECEPTOR ANTAGONISTS AS A COSMETIC AGENT FOR MITIGATING, REDUCING OR STOPPING HAIR AND HAIR LOSS
FR2812190B1 (en) * 2000-07-28 2003-01-31 Oreal USE OF NON-PROSTANOIC AGONISTS OF EP-2 AND / OR EP-4 PROSTAGLANDIN RECEPTORS AS A COSMETIC AGENT FOR MITIGATING, DECREASING OR STOPPING HAIR AND HAIR LOSS
KR100437873B1 (en) 2001-05-08 2004-06-26 연성정밀화학(주) Process for preparing prostaglandin derivatives and stereospecific starting material thereof
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
EP1594438B1 (en) 2003-02-12 2013-07-17 L'Oréal Use of an inhibitor of 15-hydroxyprostaglandin dehydrogenase in order to stimulate pigmentation of the skin or hair
US7326717B2 (en) 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
TWI495471B (en) 2003-08-12 2015-08-11 R Tech Ueno Ltd Composition and method for promoting hair growth
FR2907682B1 (en) 2006-10-26 2012-12-07 Vincience COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING AS AN ACTIVE INGREDIENT AT LEAST ONE PEPTIDE AND THE USE OF THIS PEPTIDE.
FR2920309B1 (en) 2007-08-28 2010-05-28 Galderma Res & Dev USE OF TRAVOPROST TO TREAT THE FALL OF HAIR
CN102143753B (en) * 2008-09-04 2013-07-03 参天制药株式会社 Hair growth promoter containing 15, 15-difluoroprostaglandin F2 alphaderivative as effective component is provided
WO2010064203A1 (en) 2008-12-02 2010-06-10 L'oreal Combination of reduced glutathione and amino acids for improving the quality of the hair in women
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
FR2949052B1 (en) 2009-08-13 2015-03-27 Oreal PROCESS FOR COSMETIC TREATMENT OF SCALP.
FR2951938B1 (en) 2009-10-30 2012-01-06 Oreal USE OF A PUNICA GRANATUM EXTRACT TO COMBAT CANITIS
RU2567792C2 (en) 2009-11-09 2015-11-10 Аллерган, Инк. Compositions and methods for hair growth stimulation
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
FR2978659B1 (en) 2011-08-05 2014-01-10 Oreal USE OF CANNABINOID COMPOUNDS FOR STIMULATING MELANOGENESIS
DK2838533T3 (en) 2012-04-16 2017-11-27 Univ Case Western Reserve COMPOSITIONS AND PROCEDURES FOR MODULATING 15-PGDH ACTIVITY
FR2999932B1 (en) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. USE OF PROBIOTIC MICROORGANISMS AS A MELANIN SYNTHESIS AGENT
FR2999931A1 (en) 2012-12-21 2014-06-27 Oreal USE OF PROBIOTIC MICROORGANISMS AS AN AGENT PROMOTING MELANIN SYNTHESIS
US9789116B2 (en) 2013-10-15 2017-10-17 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
US10945998B2 (en) 2015-03-08 2021-03-16 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating fibrosis
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
WO2018145080A1 (en) 2017-02-06 2018-08-09 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
MX2021005982A (en) 2018-11-21 2021-09-23 Univ Case Western Reserve Compositions and methods of modulating short-chain dehydrogenase activity.
AU2021275122A1 (en) 2020-05-20 2022-12-15 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
CN112933100B (en) * 2021-04-27 2022-06-24 中国人民解放军空军军医大学 Application of demethyleularmin in leucoderma medicament and ointment thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
EP0302147A1 (en) * 1987-08-03 1989-02-08 The Procter & Gamble Company Topical tanning compositions
FR2623716B1 (en) * 1987-11-27 1991-04-05 Lvmh Rech COMPOSITION BASED ON HYDRATED LIPID LAMID PHASES OR LIPOSOMES CONTAINING TYROSINE OR A TYROSINE DERIVATIVE AND COSMETIC OR PHARMACEUTICAL COMPOSITION, ESPECIALLY DERMATOLOGICAL, WITH PIGMENTANT ACTIVITY, INCORPORATING IT
US5352440A (en) * 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
DE4124693A1 (en) * 1991-07-22 1993-01-28 Schering Ag Use of carbocycline derivs. - esp. iloprost, cicaprost, eptaloprost, beraprost or ciprostene, for treatment of vitiligo

Also Published As

Publication number Publication date
EP0724425A1 (en) 1996-08-07
CA2174655A1 (en) 1995-04-27
WO1995011003A1 (en) 1995-04-27
JPH09504021A (en) 1997-04-22
AU8008694A (en) 1995-05-08

Similar Documents

Publication Publication Date Title
SE9303444D0 (en) New use of prostaglandins
ES2164877T3 (en) REDUCTION OF HAIR GROWTH.
CA2148652A1 (en) Substance p antagonist used in a cosmetic composition; composition thus produced
CA2135575A1 (en) Cosmetic composition containing a n-mercapto-alkyl alcanediamide as reduction agent or one of his salts cosmetically acceptable
DE60115618D1 (en) USE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS CONTAINING 2-DECARBOXY-2-PHOSPHINO PROSTAGLANDINE DERIVATIVES
GT199800197AA (en) PROCESS FOR THE SYNTHESIS OF 1,3-DIOLES
DE69532167D1 (en) INHIBITATION OF HAIR GROWTH
MX9804221A (en) Reduction of hair growth.
DE3172264D1 (en) Pre-shampoo type hair treatment composition
BR9306683A (en) Aldehyde-cured proteinaceous adhesive
DE69505651T2 (en) INHIBIT HAIR GROWTH
FI971536A0 (en) Analogues of the keratinocyte growth factor
MX9704050A (en) New dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals.
ES2092868T3 (en) USE OF DERIVATIVES OF 4-THYORRESORCINE IN A COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION OF DEPIGMENTING ACTION.
ES2174113T3 (en) NEW DERIVATIVES OF ((3-ALCOXI-FENOXI) -ETIL) -DIALQUILAMINE AND ITS USE AS LOCAL ANESTHETICS.
AU604418B2 (en) Cosmetic composition
ATE168988T1 (en) L-CARNITINE SALT, COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THIS FOR THE TREATMENT OF DERMATOSES
ES2121463T3 (en) USE OF PROCISTEIN AS A SKIN WHITENING AGENT.
DE69013972D1 (en) Cosmetic composition.
ES2088682T3 (en) SKIN TANNING AGENT.
ATE258926T1 (en) METHOD FOR PRODUCING RANITIDINE
DE69733316D1 (en) PREPARATION OF 3-FLUOROXINDOL DERIVATIVES
AU5217790A (en) 2-alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
AU1294688A (en) 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
AU666109C (en) Combination of dihydroxyacetone and of disubstituted indole derivatives for imparting to the skin a colour similar to natural tanning, process and colouring agents